Liu C, Zha Z, Zhou C, Chen Y, et al. Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)]. J Hepatol 2022 Apr 27. pii: S0168-8278(22)00240.
PMID: 35489965